“Noticefrom” increased revenue for the first 9 months by 5%, to 12.5 billion rubles


Following the results of January-September 2015 the company’s share on the Russian market of OTC drugs is 4.7%, according to the company.

MOSCOW, 2 Nov. One of the largest Russian pharmaceutical companies “Noticefrom” increased in the first nine months of 2015 revenue growth of 5% compared to the same period last year, to 12.5 billion roubles, is spoken in the message of the company.

The company does not specify the accounting standards.

“Noticefrom” showed a 5% increase in revenue, which in the reporting period amounted to 12.5 billion rubles against 11,95 billion rubles for 9 months of 2014″, — stated in the message. Following the results of January-September 2015 the company’s share on the Russian market of OTC drugs is 4.7%.

“Noticefrom” was founded in 2013. Now the company occupies the second largest share in the Russian pharmaceutical market OTC products in monetary terms.